Advanced search
Publication Cover
Platelets Volume 11, 2000 - Issue 3
Submit an article Journal homepage
23
Views
30
CrossRef citations to date
0
Altmetric
Research Article

Habitual smoking causes an abnormality in platelet thromboxane A 2 metabolism and results in an altered susceptibility to aspirin effects

Artur-Aron Weber, Sven Liesener, Andrea Schanz, Thomas Hohlfeld, Karsten Schror Institut fur Pharmakologie und Klinische Pharmakologie, Heinrich-Heine-Universit at Dusseldorf, Germany
Pages 177-182 | Published online: 07 Jul 2009

  • Wilhelmsen L. Coronary heart disease: epidemiology of smoking and intervention studies of smoking. Am Heart J1988; US: 242-9.
  • Levine PH. An acute effect of cigarette smoking on platelet function: a possible link between smoking and arterial thrombosis. Circulation 1973; 48: 619-23.
  • Hung J, Lam JYT, Lacoste L, Letchacovski G. Cigarette smoking acutely increases platelet thrombus formation in patients with coronary artery disease taking aspirin. Circulation 1995; 92: 2432-6.
  • Smith CJ, Steichen TJ, Fischer TH. Platelet aggregation in cigarette smokers: a meta-analysis. Inhal Toxicol 1998; 10: 765-93.
  • Chant C, Pagan SC, Aurora SK, Gidal BE, Joseph R. Effects of aspirin on platelet aggregation in smokers and nonsmokers. Ann Pharmacother 1997; 31: 290-3.
  • Braun M, Kramann J, Strobach H, Schrör K. Incomplete inhibition of platelet secretion by low-dose aspirin. Platelets 1994; 5: 325-31.
  • Weber A-A, Strobach H, Schrör K. Direct inhibition of platelet function by organic nitrates via nitric oxide formation. Eur J Pharmacol 1993; 247: 29-37.
  • Schrör K, Seidel H. Blood-vessel wall arachidonate metabolism and its pharmacological modification in a new in vitro assay system. Naunyn-Schmiedeberg's Arch Pharmacol 1988; 337: 177-82.
  • Santos MT, Valles J, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Eiroa AM, Aznar J. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. J Clin Invest 1991; 87: 571-80.
  • Davis JW, Davis RF. Prevention of cigarette smoking-induced platelet aggregate formation by aspirin. Arch Intern Med 1981; 141: 206-7.
  • Davis JW, Hartman CR, Lewis HD, Shelton L, Eigenberg DA, Hassanein KM, Hignite CE, Ruttinger HA. Cigarette smokinginduced enhancement of platelet function: lack of prevention by aspirin in men with coronary artery disease. J Lab Clin Med 1985; 105: 479-83.
  • Marasini B, Biondi ML, Barbesti S, Zatta G, Agostoni A. Cigarette smoking and platelet function. Thromb Res 1986; 44: 85-94.
  • Foo LC, Roshidah I, Aimy MB. Platelets of habitual smokers have reduced susceptibility to aggregating agent. Thromb Haemost 1991; 65: 317-9.
  • Barrow SE, Ward PS, Sleightholm MA, Ritter JM, Dollery CT. Cigarette smoking: profiles of thromboxane- and prostacyclinderived products in human urine. Biochim Biophys Acta 1989; 663: 121-7.
  • Murray JJ, Nowak J, Gates JA, FitzGerald GA. Platelet-vessel wall interactions in individuals who smoke cigarettes. Adv Exp Med Biol 1990; 273: 189-98.
  • Uedelhoven WM, Rutzel A, Meese CO, Weber PC. Smoking alters thromboxane metabolism in man. Biochim Biophys Acta 1991; 1081: 197-201.
  • Wennmalm A, Benthin G, Granstrom EF, Persson L, Petersson AS, Winell S. Relation between tobacco use and urinary excretion of thromboxane A2 and prostacyclin metabolites in young men. Circulation 1991; 83: 1698-704.
  • Dotevall A, Rangemark C, Eriksson E, Kutti J, Wadenvik H, Wennmalm A. Cigarette smoking increases thromboxane A2 formation without affecting platelet survival in young healthy females. Thromb Haemost 1992; 68: 583-8.
  • Benovitz NL, FitzGerald GA, Wilson M, Zhang Q. Nicotine effects on eicosanoid formation and hemostatic function: comparison of transdermal nicotine and cigarette smoking. J Am Coll Cardiol 1993; 22: 1159-67.
  • Rangemark C, Ciabattoni G, Wennmalm A. Excretion of thromboxane metabolites in healthy women after cessation of smoking. Arterioscler Thromb 1993; 13: 777-82.
  • Weber A-A, Zimmermann KC, Meyer-Kirchrath J, Schrör K. Cyclooxygenase-2 in human platelets as a possible factor in aspirin resitance. Lancet 1999; 353: 900.
  • Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Arm Rev Pharmacol Toxicol 1998; 38: 97-120.
  • Zimmermann N, Kienzle P, Weber A-A, Gams E, Hohlfeld T, Schrör K. Platelet aspirin resistance is associated with an increased platelet content of cyclooxygenase-2. Circulation 1999; 100(Suppl): I-327.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.